Odyssey Health (ODYY) EBIT Growth (1y) (2015 - 2026)
Odyssey Health (ODYY) EBIT Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 16.18% |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - | -130.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -130.56% |
| Jan 31, 2026 | -16.19% |
| Oct 31, 2025 | 47.67% |
| Jul 31, 2025 | -165.57% |
| Apr 30, 2025 | 65.34% |
| Jan 31, 2025 | 86.47% |
| Oct 31, 2024 | -66.87% |
| Jul 31, 2024 | 136.24% |
| Apr 30, 2024 | 65.98% |
| Jan 31, 2024 | 22.14% |
| Oct 31, 2023 | 83.29% |
| Jul 31, 2023 | 64.29% |
| Apr 30, 2023 | 61.81% |
| Jan 31, 2023 | 24.77% |
| Oct 31, 2022 | -45.36% |
| Jul 31, 2022 | 29.63% |
| Apr 30, 2022 | 76.30% |
| Jan 31, 2022 | -211.77% |
| Oct 31, 2021 | -172.12% |
| Jul 31, 2021 | -125.45% |